Скачать или смотреть Europe's €1.14 Trillion Biotech Future- Innovation or Imitation? | FII PRIORITY 2025

From Prevention to Precision: Is Biotech the Answer? took place at the National Theatre of Opera and Ballet on DAY 2, May 17, 2025 of the Special Edition of #FIIPRIORITY in #Tirana

European biotech projects €1.14 trillion growth by 2030, yet faces critical capital deployment challenges. This dynamic dialogue revealed how Europe's world-class talent pools navigate complex funding landscapes while confronting the reality that high-growth startups often struggle with conservative institutional approaches to Series B financing.

The conversation illuminated Europe's exceptional talent advantages while addressing fragmented regulatory frameworks across 27 markets that challenge biotech scaling. Speakers explored how prevention-focused strategies could unlock over €10 billion in annual savings while examining precision medicine's transformative potential for matching patients with optimal treatments.

Can Europe convert its remarkable talent pools into sustainable leadership in global healthcare innovation?

SPEAKERS:
Dr. Viswa Colluru, Founder & CEO, Enveda
Nicolas Bouzou, Founder & Director, Asterés
Dr. Tomislav Mihaljevic, MD, CEO & President, ​⁠‪@clevelandclinic‬
Youssef Sebban, Co-Founder & Managing Partner, Eckuity Capital

MODERATOR:

Dr. François Sarkozy, Founder & CEO, FSNB Health & Care